P3 Health Partners Inc (PIII)
0.215
+0.01
(+5.50%)
USD |
NASDAQ |
Nov 21, 16:00
0.2199
0.00 (0.00%)
After-Hours: 20:00
P3 Health Partners Enterprise Value: 248.89M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 248.89M |
| November 20, 2024 | 247.06M |
| November 19, 2024 | 248.22M |
| November 18, 2024 | 248.45M |
| November 15, 2024 | 251.09M |
| November 14, 2024 | 247.97M |
| November 13, 2024 | 254.57M |
| November 12, 2024 | 277.45M |
| November 11, 2024 | 278.30M |
| November 08, 2024 | 274.86M |
| November 07, 2024 | 274.46M |
| November 06, 2024 | 274.10M |
| November 05, 2024 | 271.04M |
| November 04, 2024 | 271.96M |
| November 01, 2024 | 273.80M |
| October 31, 2024 | 272.00M |
| October 30, 2024 | 274.59M |
| October 29, 2024 | 276.59M |
| October 28, 2024 | 277.35M |
| October 25, 2024 | 279.65M |
| October 24, 2024 | 285.04M |
| October 23, 2024 | 291.13M |
| October 22, 2024 | 285.14M |
| October 21, 2024 | 283.13M |
| October 18, 2024 | 287.41M |
| Date | Value |
|---|---|
| October 17, 2024 | 291.46M |
| October 16, 2024 | 273.78M |
| October 15, 2024 | 269.28M |
| October 14, 2024 | 265.07M |
| October 11, 2024 | 264.08M |
| October 10, 2024 | 264.44M |
| October 09, 2024 | 266.50M |
| October 08, 2024 | 272.49M |
| October 07, 2024 | 274.93M |
| October 04, 2024 | 275.10M |
| October 03, 2024 | 274.80M |
| October 02, 2024 | 276.88M |
| October 01, 2024 | 276.88M |
| September 30, 2024 | 276.44M |
| September 27, 2024 | 322.27M |
| September 26, 2024 | 320.65M |
| September 25, 2024 | 321.51M |
| September 24, 2024 | 321.96M |
| September 23, 2024 | 321.85M |
| September 20, 2024 | 328.41M |
| September 19, 2024 | 330.99M |
| September 18, 2024 | 333.27M |
| September 17, 2024 | 337.49M |
| September 16, 2024 | 339.54M |
| September 13, 2024 | 338.64M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
247.06M
Minimum
Nov 20 2024
2.068B
Maximum
Mar 22 2022
913.07M
Average
670.19M
Median
Dec 31 2022
Enterprise Value Benchmarks
| American Shared Hospital Services | 34.29M |
| Omnicell Inc | 2.033B |
| Astrana Health Inc | 1.813B |
| Cryo-Cell International Inc | 75.52M |
| Biote Corp | 275.12M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -46.51M |
| Revenue (Quarterly) | 362.12M |
| Total Expenses (Quarterly) | 469.11M |
| EPS Diluted (Quarterly) | -0.31 |
| Profit Margin (Quarterly) | -12.84% |
| Earnings Yield | -400.0% |
| Normalized Earnings Yield | -439.80 |